Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is one of the 13 Best Healthcare Stocks to Buy Under $10. On June 12, Amneal ...

Here is how Amneal Pharmaceuticals (AMRX) and AtriCure (ATRC) have performed compared to their sector so far this year.

Amneal Pharmaceuticals, Inc. (“Amneal”) (Nasdaq: AMRX) announced that its subsidiary, Amneal Pharmaceuticals LLC (the “Issuer”), is seeking to borrow $1.800 billion aggregate ...

In trading on Tuesday, shares of Amneal Pharmaceuticals Inc (Symbol: AMRX) crossed above their 200 day moving average of $8.13, changing hands as high as $8.17 per share. Amneal Pharmaceuticals ...

The Issuer intends to use the net proceeds of the new term B loans and the notes to refinance its existing term B loans in full, to repay a portion of outstanding amounts borrowed under its ABL ...

In its Specialty segment, Amneal has a growing portfolio of branded pharmaceuticals focused primarily on central nervous system and endocrine disorders.

Has Amneal Pharmaceuticals (AMRX) been one of those stocks this year? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that ...

Unaudited Preliminary Financial Results for the Second Quarter Ended June 30, 2025 Net revenue of $720 million to $730 million, an increase of approximately 3% versus the same period in 2024 Income ...

Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) is among the best growth stocks to invest in for the next 5 years. Gautam Patel, the director of Amneal Pharmaceuticals, Inc.

BRIDGEWATER, N.J., July 09, 2025 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) ('Amneal” or the 'Company”), a global biopharmaceutical company, today announced that the Company will ...

Amneal to Report Second Quarter 2025 Results on August 5, 2025 Jul. 09, 2025 8:00 AM ET Amneal Pharmaceuticals, Inc. (AMRX) ...